| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.51e-07 | 14 | 72 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.79e-07 | 4 | 72 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.56e-06 | 24 | 72 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.48e-06 | 8 | 72 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.48e-06 | 8 | 72 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.56e-06 | 27 | 72 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 7.26e-06 | 11 | 72 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.48e-06 | 35 | 72 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.28e-05 | 2 | 72 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.98e-05 | 15 | 72 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.91e-05 | 49 | 72 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 7.66e-05 | 4 | 72 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.27e-04 | 5 | 72 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.27e-04 | 5 | 72 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.27e-04 | 5 | 72 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.48e-04 | 34 | 72 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 7.94e-04 | 115 | 72 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | FK506 binding | 8.27e-04 | 12 | 72 | 2 | GO:0005528 | |
| GeneOntologyMolecularFunction | macrolide binding | 1.13e-03 | 14 | 72 | 2 | GO:0005527 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.48e-03 | 231 | 72 | 5 | GO:0005085 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 2.32e-03 | 507 | 72 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 2.32e-03 | 507 | 72 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | heme binding | 2.33e-03 | 154 | 72 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.92e-03 | 164 | 72 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.05e-03 | 166 | 72 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.35e-03 | 279 | 72 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | transition metal ion binding | AGBL4 BMI1 UBR2 CYP2C19 CYP2C8 ZCCHC12 CYP2C9 CYP2C18 AICDA PHC1 PPM1B | 3.39e-03 | 1189 | 72 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.13e-03 | 441 | 72 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 5.31e-03 | 194 | 72 | 4 | GO:0016705 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 9.52e-07 | 22 | 72 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.44e-05 | 14 | 72 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 6.87e-05 | 23 | 72 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 7.48e-05 | 202 | 72 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 9.39e-05 | 68 | 72 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.01e-04 | 309 | 72 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 1.79e-04 | 6 | 72 | 2 | GO:0016098 | |
| Domain | Cyt_P450_E_grp-I | 2.68e-05 | 45 | 72 | 4 | IPR002401 | |
| Domain | srGAP2 | 4.39e-05 | 3 | 72 | 2 | IPR030252 | |
| Domain | Cyt_P450_CS | 5.15e-05 | 53 | 72 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.87e-05 | 57 | 72 | 4 | PS00086 | |
| Domain | KRAB | 6.93e-05 | 358 | 72 | 8 | PS50805 | |
| Domain | KRAB | 6.93e-05 | 358 | 72 | 8 | PF01352 | |
| Domain | - | 7.36e-05 | 58 | 72 | 4 | 1.10.630.10 | |
| Domain | p450 | 7.36e-05 | 58 | 72 | 4 | PF00067 | |
| Domain | Cyt_P450 | 8.41e-05 | 60 | 72 | 4 | IPR001128 | |
| Domain | KRAB | 8.55e-05 | 369 | 72 | 8 | SM00349 | |
| Domain | KRAB | 8.72e-05 | 370 | 72 | 8 | IPR001909 | |
| Domain | ELAD_HUD_SF | 8.75e-05 | 4 | 72 | 2 | IPR006548 | |
| Domain | Hud_Sxl_RNA | 6.46e-04 | 10 | 72 | 2 | IPR002343 | |
| Domain | Elongated_TPR_rpt_dom | 7.88e-04 | 11 | 72 | 2 | IPR023114 | |
| Domain | DOCK_C | 7.88e-04 | 11 | 72 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 7.88e-04 | 11 | 72 | 2 | IPR027007 | |
| Domain | DHR_2 | 7.88e-04 | 11 | 72 | 2 | PS51651 | |
| Domain | DHR_1 | 7.88e-04 | 11 | 72 | 2 | PS51650 | |
| Domain | DOCK-C2 | 7.88e-04 | 11 | 72 | 2 | PF14429 | |
| Domain | DHR-2 | 7.88e-04 | 11 | 72 | 2 | IPR027357 | |
| Domain | DHR-2 | 7.88e-04 | 11 | 72 | 2 | PF06920 | |
| Domain | DOCK | 7.88e-04 | 11 | 72 | 2 | IPR026791 | |
| Domain | Znf_C2H2-like | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 DHX34 ZNF284 ZNF222 | 9.15e-04 | 796 | 72 | 10 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 DHX34 ZNF284 ZNF222 | 1.03e-03 | 808 | 72 | 10 | SM00355 |
| Domain | FKBP_PPIASE | 1.70e-03 | 16 | 72 | 2 | PS50059 | |
| Domain | FKBP_C | 1.70e-03 | 16 | 72 | 2 | PF00254 | |
| Domain | PPIase_FKBP | 1.92e-03 | 17 | 72 | 2 | IPR023566 | |
| Domain | PPIase_FKBP_dom | 2.66e-03 | 20 | 72 | 2 | IPR001179 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 ZNF284 ZNF222 | 2.86e-03 | 775 | 72 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 ZNF284 ZNF222 | 2.91e-03 | 777 | 72 | 9 | PS00028 |
| Domain | FCH | 3.22e-03 | 22 | 72 | 2 | PF00611 | |
| Domain | FCH | 3.22e-03 | 22 | 72 | 2 | SM00055 | |
| Domain | FCH_dom | 3.52e-03 | 23 | 72 | 2 | IPR001060 | |
| Domain | Znf_C2H2 | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 ZNF284 ZNF222 | 3.67e-03 | 805 | 72 | 9 | IPR007087 |
| Domain | F_BAR | 4.15e-03 | 25 | 72 | 2 | IPR031160 | |
| Domain | F_BAR | 4.15e-03 | 25 | 72 | 2 | PS51741 | |
| Domain | zf-C2H2 | 5.10e-03 | 693 | 72 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 5.14e-03 | 694 | 72 | 8 | IPR013087 | |
| Pathway | REACTOME_XENOBIOTICS | 2.15e-06 | 23 | 58 | 4 | M5372 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 3.65e-06 | 8 | 58 | 3 | M27135 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 5.46e-06 | 9 | 58 | 3 | M27143 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 5.67e-06 | 29 | 58 | 4 | M2920 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.07e-05 | 11 | 58 | 3 | M27130 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.42e-05 | 12 | 58 | 3 | M48064 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 2.33e-05 | 14 | 58 | 3 | MM15842 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 8.34e-05 | 21 | 58 | 3 | M39631 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 9.27e-05 | 58 | 58 | 4 | M5410 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.20e-04 | 62 | 58 | 4 | M39653 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.26e-04 | 24 | 58 | 3 | M46445 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.36e-04 | 64 | 58 | 4 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.36e-04 | 64 | 58 | 4 | M9488 | |
| Pathway | REACTOME_XENOBIOTICS | 1.43e-04 | 25 | 58 | 3 | MM14846 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.93e-04 | 70 | 58 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.15e-04 | 72 | 58 | 4 | M9257 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 2.47e-04 | 6 | 58 | 2 | M27909 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 3.45e-04 | 7 | 58 | 2 | M39515 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 3.45e-04 | 7 | 58 | 2 | MM14856 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 4.58e-04 | 8 | 58 | 2 | M27891 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 5.88e-04 | 9 | 58 | 2 | M39819 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.77e-04 | 44 | 58 | 3 | M45014 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 8.74e-04 | 104 | 58 | 4 | M738 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 8.93e-04 | 11 | 58 | 2 | MM14863 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 9.16e-04 | 183 | 58 | 5 | M39588 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.07e-03 | 12 | 58 | 2 | MM14847 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.07e-03 | 12 | 58 | 2 | MM15616 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 1.47e-03 | 14 | 58 | 2 | M22025 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.82e-03 | 59 | 58 | 3 | M27140 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 1.92e-03 | 16 | 58 | 2 | M27403 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.52e-03 | 66 | 58 | 3 | MM14839 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 2.72e-03 | 19 | 58 | 2 | M27889 | |
| Pubmed | 2.85e-12 | 20 | 74 | 6 | 12743021 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 2009263 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 21798861 | ||
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 1.89e-11 | 4 | 74 | 4 | 7704034 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 23755828 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 19706858 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 28687336 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 9.25e-09 | 3 | 74 | 3 | 10704292 | |
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 9.25e-09 | 3 | 74 | 3 | 8530044 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 21173785 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 15102943 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 35134542 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 24430292 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 9.25e-09 | 3 | 74 | 3 | 21977947 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 20665013 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 9.25e-09 | 3 | 74 | 3 | 19954515 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8095407 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 23118231 | ||
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 1.86e-08 | 14 | 74 | 4 | 19290787 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 3.37e-08 | 16 | 74 | 4 | 17048007 | |
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 3.69e-08 | 4 | 74 | 3 | 16025294 | |
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 28990182 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 8.91e-08 | 20 | 74 | 4 | 9890157 | |
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 9.22e-08 | 5 | 74 | 3 | 20857895 | |
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 19415824 | ||
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 1.84e-07 | 6 | 74 | 3 | 19578179 | |
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 1.84e-07 | 6 | 74 | 3 | 17635176 | |
| Pubmed | 4.96e-07 | 30 | 74 | 4 | 20529763 | ||
| Pubmed | 1.10e-06 | 10 | 74 | 3 | 19651758 | ||
| Pubmed | 1.10e-06 | 10 | 74 | 3 | 20602612 | ||
| Pubmed | 1.51e-06 | 11 | 74 | 3 | 15039299 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.51e-06 | 11 | 74 | 3 | 15469410 | |
| Pubmed | 2.01e-06 | 12 | 74 | 3 | 15319333 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.69e-06 | 183 | 74 | 6 | 31932471 | |
| Pubmed | 3.31e-06 | 14 | 74 | 3 | 20970553 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7574697 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16198656 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30562214 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26122864 | ||
| Pubmed | A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. | 4.47e-06 | 2 | 74 | 2 | 21935478 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24288737 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 4.47e-06 | 2 | 74 | 2 | 15569425 | |
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 4.47e-06 | 2 | 74 | 2 | 22491019 | |
| Pubmed | FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action. | 4.47e-06 | 2 | 74 | 2 | 25714272 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20796173 | ||
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 4.47e-06 | 2 | 74 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 4.47e-06 | 2 | 74 | 2 | 18511451 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28686288 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18694831 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20808793 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 4.47e-06 | 2 | 74 | 2 | 14634042 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22918969 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24749623 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15606441 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32567426 | ||
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 4.47e-06 | 2 | 74 | 2 | 10908295 | |
| Pubmed | Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. | 4.47e-06 | 2 | 74 | 2 | 17868191 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32868386 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27617498 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 1847130 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16873909 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28513222 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 4.47e-06 | 2 | 74 | 2 | 17599801 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19038035 | ||
| Pubmed | Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. | 4.47e-06 | 2 | 74 | 2 | 8110777 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 106274 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15385837 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25518510 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 4.47e-06 | 2 | 74 | 2 | 8333835 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16372821 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15776277 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15842554 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24492587 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 4.47e-06 | 2 | 74 | 2 | 35748067 | |
| Pubmed | Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days. | 4.47e-06 | 2 | 74 | 2 | 16232205 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20890775 | ||
| Pubmed | The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals. | 4.47e-06 | 2 | 74 | 2 | 35780191 | |
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 4.47e-06 | 2 | 74 | 2 | 32587777 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20845310 | ||
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 4.47e-06 | 2 | 74 | 2 | 17201743 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32683556 | ||
| Pubmed | Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers. | 4.47e-06 | 2 | 74 | 2 | 18548238 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18216720 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15855721 | ||
| Pubmed | Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. | 4.47e-06 | 2 | 74 | 2 | 9721182 | |
| Pubmed | Genetic variance in CYP2C8 and increased risk of myocardial infarction. | 4.47e-06 | 2 | 74 | 2 | 20436375 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19847408 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 4.47e-06 | 2 | 74 | 2 | 24519941 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 14623888 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7841444 | ||
| Pubmed | Cytochrome P450 polymorphisms in patients with Behcet's disease. | 4.47e-06 | 2 | 74 | 2 | 17269966 | |
| Pubmed | Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. | 4.47e-06 | 2 | 74 | 2 | 14646690 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17627038 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24694367 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20726698 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 11950794 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 34057812 | ||
| Interaction | CYP2C19 interactions | 4.54e-07 | 5 | 73 | 3 | int:CYP2C19 | |
| Interaction | CYP2C18 interactions | 2.61e-06 | 27 | 73 | 4 | int:CYP2C18 | |
| Interaction | ZNF284 interactions | 1.61e-05 | 14 | 73 | 3 | int:ZNF284 | |
| Cytoband | 10q24 | 2.54e-05 | 35 | 74 | 3 | 10q24 | |
| Cytoband | 19q13.2 | 1.49e-04 | 164 | 74 | 4 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 2.88e-04 | 195 | 74 | 4 | chr10q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 6.68e-04 | 1192 | 74 | 8 | chr19q13 | |
| GeneFamily | Cytochrome P450 family 2 | 5.31e-06 | 35 | 60 | 4 | 1001 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF627 ZNF155 ZNF177 ZNF223 ZNF224 ZNF112 ANKZF1 ZNF284 ZNF222 | 5.62e-04 | 718 | 60 | 9 | 28 |
| GeneFamily | FKBP prolyl isomerases | 1.60e-03 | 18 | 60 | 2 | 910 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 2.62e-03 | 23 | 60 | 2 | 1288 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-07 | 197 | 74 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 8.69e-06 | 167 | 74 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 175 | 74 | 5 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 189 | 74 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 190 | 74 | 5 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 190 | 74 | 5 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 190 | 74 | 5 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-05 | 192 | 74 | 5 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 199 | 74 | 5 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 199 | 74 | 5 | bbb4798d6a24e756fea744a151ba67c1bafbac9a | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 8.73e-05 | 140 | 74 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 142 | 74 | 4 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 146 | 74 | 4 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 150 | 74 | 4 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 153 | 74 | 4 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 161 | 74 | 4 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-04 | 169 | 74 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 169 | 74 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 170 | 74 | 4 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 171 | 74 | 4 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cbln2_(Neuron.Slc17a6.Rora.Cbln2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 67 | 74 | 3 | 5202166895fd109ad0d7584fc35c74814a59ce2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 175 | 74 | 4 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 175 | 74 | 4 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 176 | 74 | 4 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 176 | 74 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-04 | 177 | 74 | 4 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 177 | 74 | 4 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-04 | 177 | 74 | 4 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-04 | 178 | 74 | 4 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 179 | 74 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.24e-04 | 179 | 74 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.24e-04 | 179 | 74 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 179 | 74 | 4 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 180 | 74 | 4 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 2.29e-04 | 180 | 74 | 4 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.34e-04 | 181 | 74 | 4 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 2.34e-04 | 181 | 74 | 4 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-04 | 181 | 74 | 4 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-04 | 182 | 74 | 4 | 86a2330ada7637144a67afbf9f3a902901ab1130 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.39e-04 | 182 | 74 | 4 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 2.44e-04 | 183 | 74 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-04 | 184 | 74 | 4 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.54e-04 | 185 | 74 | 4 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-04 | 185 | 74 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-04 | 186 | 74 | 4 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.60e-04 | 186 | 74 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.60e-04 | 186 | 74 | 4 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-04 | 187 | 74 | 4 | 1bba994aaaa9825b54aaeaff3829850267bc4602 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-04 | 187 | 74 | 4 | d6ac351e7aeba98851d308c14ac395044fe4fbbb | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.70e-04 | 188 | 74 | 4 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.70e-04 | 188 | 74 | 4 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 189 | 74 | 4 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.76e-04 | 189 | 74 | 4 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-04 | 189 | 74 | 4 | a28e0922e10013ae79266f6a3f9305e6ee614d8b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 189 | 74 | 4 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 189 | 74 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 189 | 74 | 4 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.81e-04 | 190 | 74 | 4 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-04 | 190 | 74 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 190 | 74 | 4 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 191 | 74 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 191 | 74 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 192 | 74 | 4 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.93e-04 | 192 | 74 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 2.93e-04 | 192 | 74 | 4 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-04 | 192 | 74 | 4 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.93e-04 | 192 | 74 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 2.93e-04 | 192 | 74 | 4 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 192 | 74 | 4 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 192 | 74 | 4 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 2.99e-04 | 193 | 74 | 4 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 193 | 74 | 4 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 194 | 74 | 4 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-04 | 194 | 74 | 4 | 06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 194 | 74 | 4 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-04 | 194 | 74 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 3.05e-04 | 194 | 74 | 4 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 3.05e-04 | 194 | 74 | 4 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 196 | 74 | 4 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 196 | 74 | 4 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 3.23e-04 | 197 | 74 | 4 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-04 | 197 | 74 | 4 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| Computational | Cytochrome P450. | 2.60e-07 | 14 | 45 | 4 | MODULE_106 | |
| Computational | Genes in the cancer module 135. | 1.48e-04 | 25 | 45 | 3 | MODULE_135 | |
| Drug | 4',5-dihydroxydiclofenac | 1.53e-09 | 6 | 74 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 1.53e-09 | 6 | 74 | 4 | CID000112230 | |
| Drug | 5-hydroxydiclofenac | 4.99e-08 | 12 | 74 | 4 | CID003052566 | |
| Drug | propionanilide | 1.00e-07 | 14 | 74 | 4 | CID000012107 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.37e-07 | 15 | 74 | 4 | ctd:C586542 | |
| Drug | Azamulinum | 3.04e-07 | 18 | 74 | 4 | CID003086060 | |
| Drug | D 703 | 3.04e-07 | 18 | 74 | 4 | CID000054088 | |
| Drug | bufuralol | 3.28e-07 | 5 | 74 | 3 | ctd:C010831 | |
| Drug | hydroxytolbutamide | 3.84e-07 | 19 | 74 | 4 | CID000003656 | |
| Drug | 3C etc | 4.79e-07 | 20 | 74 | 4 | CID000164045 | |
| Drug | 6-hydroxymelatonin | 5.98e-07 | 50 | 74 | 5 | CID000001864 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 6.55e-07 | 6 | 74 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 6.55e-07 | 6 | 74 | 3 | CID006443527 | |
| Drug | triazolam | 8.83e-07 | 54 | 74 | 5 | CID000005556 | |
| Drug | 5-fluorotryptamine | 1.14e-06 | 7 | 74 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 1.14e-06 | 7 | 74 | 3 | CID005486899 | |
| Drug | 16-O-demethylaconitine | 1.14e-06 | 7 | 74 | 3 | ctd:C486136 | |
| Drug | Tolbutamide | 1.23e-06 | 25 | 74 | 4 | ctd:D014044 | |
| Drug | 1,4-naphthoquinone | 1.46e-06 | 26 | 74 | 4 | ctd:C035342 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 1.82e-06 | 8 | 74 | 3 | CID006439499 | |
| Drug | 11-HODE | 1.82e-06 | 8 | 74 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 1.82e-06 | 8 | 74 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.82e-06 | 8 | 74 | 3 | ctd:C585955 | |
| Drug | (hydrochloride) | 2.30e-06 | 29 | 74 | 4 | CID000004923 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 2.73e-06 | 9 | 74 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 2.73e-06 | 9 | 74 | 3 | ctd:D000074 | |
| Drug | 5-chlorotryptamine | 2.73e-06 | 9 | 74 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 2.73e-06 | 9 | 74 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 2.73e-06 | 9 | 74 | 3 | ctd:C000588958 | |
| Drug | Tryptamines | 2.73e-06 | 9 | 74 | 3 | ctd:D014363 | |
| Drug | BP-7,8-oxide | 3.45e-06 | 32 | 74 | 4 | CID000037455 | |
| Drug | DMEs | 3.48e-06 | 71 | 74 | 5 | CID003038361 | |
| Drug | sitaxsentan | 3.89e-06 | 10 | 74 | 3 | ctd:C106276 | |
| Drug | norketobemidone | 3.89e-06 | 10 | 74 | 3 | CID000161154 | |
| Drug | Haloperidol metabolite I | 5.34e-06 | 11 | 74 | 3 | CID000038282 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 5.34e-06 | 11 | 74 | 3 | ctd:C507866 | |
| Drug | 4-(N-propionylanilino)piperidine | 7.10e-06 | 12 | 74 | 3 | CID000259381 | |
| Drug | carveol | 7.10e-06 | 12 | 74 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 7.10e-06 | 12 | 74 | 3 | ctd:C047386 | |
| Drug | norclozapine | 7.10e-06 | 12 | 74 | 3 | ctd:C058272 | |
| Drug | AC1L18GM | 9.21e-06 | 13 | 74 | 3 | CID000000092 | |
| Drug | 7-hydroxyquinoline | 9.21e-06 | 13 | 74 | 3 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 9.21e-06 | 13 | 74 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 9.21e-06 | 13 | 74 | 3 | CID000036727 | |
| Drug | furafylline | 9.50e-06 | 41 | 74 | 4 | CID000003433 | |
| Drug | dibenzylfluorescein | 1.04e-05 | 2 | 74 | 2 | ctd:C558664 | |
| Drug | 5-MeO-DIPT | 1.17e-05 | 14 | 74 | 3 | CID000151182 | |
| Drug | sulfaphenazole | 1.26e-05 | 44 | 74 | 4 | CID000005335 | |
| Drug | polybrominated biphenyl | 1.26e-05 | 44 | 74 | 4 | CID000042948 | |
| Drug | 4-hydroxymephenytoin | 1.46e-05 | 15 | 74 | 3 | CID000119507 | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 1.79e-05 | 16 | 74 | 3 | ctd:C571725 | |
| Drug | Amodiaquine | 1.79e-05 | 16 | 74 | 3 | ctd:D000655 | |
| Drug | 6-hydroxychlorzoxazone | 1.79e-05 | 16 | 74 | 3 | CID000002734 | |
| Drug | 1-phenylazo-2-naphthol | 1.79e-05 | 16 | 74 | 3 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 1.79e-05 | 16 | 74 | 3 | ctd:C495657 | |
| Drug | felodipine | 1.87e-05 | 169 | 74 | 6 | CID000003333 | |
| Drug | 19-HETE | 1.95e-05 | 49 | 74 | 4 | CID006439528 | |
| Drug | diosmetin | 2.17e-05 | 17 | 74 | 3 | ctd:C039602 | |
| Drug | noralfentanil | 2.17e-05 | 17 | 74 | 3 | CID000162172 | |
| Drug | 7-benzyloxyquinoline | 2.60e-05 | 18 | 74 | 3 | CID003035604 | |
| Drug | pleuromutilin | 2.60e-05 | 18 | 74 | 3 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 2.60e-05 | 18 | 74 | 3 | CID000097389 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.67e-05 | 180 | 74 | 6 | 5203_UP | |
| Drug | D 617 | 3.08e-05 | 19 | 74 | 3 | CID000093168 | |
| Drug | 6|A-Hydroxycortisol | 3.08e-05 | 19 | 74 | 3 | CID000150985 | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.11e-05 | 185 | 74 | 6 | 2551_UP | |
| Drug | 5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione | 3.12e-05 | 3 | 74 | 2 | ctd:C502236 | |
| Drug | picoxystrobin | 3.12e-05 | 3 | 74 | 2 | ctd:C556557 | |
| Drug | 2-hydroxychlorpropamide | 3.12e-05 | 3 | 74 | 2 | CID003082454 | |
| Drug | Cyclohexenes | 3.12e-05 | 3 | 74 | 2 | ctd:D053138 | |
| Drug | mono-N-demethyladinazolam | 3.12e-05 | 3 | 74 | 2 | ctd:C050132 | |
| Drug | ortho-Aminobenzoates | 3.12e-05 | 3 | 74 | 2 | ctd:D062367 | |
| Drug | Delavirdine | 3.12e-05 | 3 | 74 | 2 | ctd:D020008 | |
| Drug | N'-nitrosoanatabine | 3.61e-05 | 20 | 74 | 3 | CID000051291 | |
| Drug | tamoxifen N-oxide | 3.61e-05 | 20 | 74 | 3 | CID003033895 | |
| Drug | 3-methoxymorphinan | 3.61e-05 | 20 | 74 | 3 | CID000001671 | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 5235_UP | |
| Drug | AC1L21VM | 4.20e-05 | 21 | 74 | 3 | CID000039524 | |
| Drug | nirvanol | 4.20e-05 | 21 | 74 | 3 | CID000091480 | |
| Drug | zafirlukast | 4.20e-05 | 21 | 74 | 3 | ctd:C062735 | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 4.29e-05 | 196 | 74 | 6 | 4392_DN | |
| Drug | 1,1-dichloroethylene | 4.37e-05 | 60 | 74 | 4 | CID000006366 | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 3575_UP | |
| Drug | Lansoprazole | 4.66e-05 | 61 | 74 | 4 | ctd:D064747 | |
| Drug | BP-4,5-oxide | 4.66e-05 | 61 | 74 | 4 | CID000037786 | |
| Drug | N'-nitrosoanabasine | 4.85e-05 | 22 | 74 | 3 | CID000014335 | |
| Drug | azoline | 4.85e-05 | 22 | 74 | 3 | CID003013050 | |
| Drug | chlorzoxazone | 5.30e-05 | 63 | 74 | 4 | CID000002733 | |
| Drug | 3-hydroxymethylantipyrine | 5.57e-05 | 23 | 74 | 3 | CID000123963 | |
| Drug | 3'-amino-3'-deoxythymidine | 5.57e-05 | 23 | 74 | 3 | CID000108074 | |
| Drug | thiocoraline | 6.23e-05 | 4 | 74 | 2 | ctd:C109005 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 6.23e-05 | 4 | 74 | 2 | ctd:C558737 | |
| Drug | 4-isopropylphenol | 6.23e-05 | 4 | 74 | 2 | ctd:C028690 | |
| Drug | 7,8-dihydromethysticin | 6.23e-05 | 4 | 74 | 2 | ctd:C107882 | |
| Drug | methysticin | 6.23e-05 | 4 | 74 | 2 | ctd:C076881 | |
| Drug | Sulfadiazine | 6.23e-05 | 4 | 74 | 2 | ctd:D013411 | |
| Drug | rabeprazole-thioether | 6.23e-05 | 4 | 74 | 2 | ctd:C523099 | |
| Drug | N-nitrosomethylethylamine | 6.35e-05 | 24 | 74 | 3 | CID000025418 | |
| Drug | 5-hydroxythalidomide | 6.35e-05 | 24 | 74 | 3 | ctd:C544471 | |
| Drug | cinnamic acid | 6.35e-05 | 24 | 74 | 3 | ctd:C029010 | |
| Disease | X-21258 measurement | 1.39e-08 | 3 | 72 | 3 | EFO_0800802 | |
| Disease | X-14473 measurement | 5.87e-06 | 2 | 72 | 2 | EFO_0021370 | |
| Disease | cyclo(leu-pro) measurement | 1.76e-05 | 3 | 72 | 2 | EFO_0800676 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 6.51e-05 | 88 | 72 | 4 | EFO_0803332 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 8.77e-05 | 95 | 72 | 4 | EFO_0803331 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 1.22e-04 | 7 | 72 | 2 | EFO_0800655 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.09e-04 | 9 | 72 | 2 | EFO_0600040 | |
| Disease | X-11308 measurement | 3.18e-04 | 11 | 72 | 2 | EFO_0800693 | |
| Disease | Major Depressive Disorder | 3.25e-04 | 243 | 72 | 5 | C1269683 | |
| Disease | ecosanoids measurement | 3.34e-04 | 55 | 72 | 3 | EFO_0020044 | |
| Disease | thymol sulfate measurement | 3.81e-04 | 12 | 72 | 2 | EFO_0021170 | |
| Disease | Unipolar Depression | 4.34e-04 | 259 | 72 | 5 | C0041696 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 5.24e-04 | 14 | 72 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 6.04e-04 | 15 | 72 | 2 | EFO_0800301 | |
| Disease | Autosomal recessive primary microcephaly | 6.04e-04 | 15 | 72 | 2 | cv:C3711387 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 6.89e-04 | 16 | 72 | 2 | EFO_0800305 | |
| Disease | metabolonic lactone sulfate measurement | 9.77e-04 | 19 | 72 | 2 | EFO_0800659 | |
| Disease | Primary microcephaly | 1.31e-03 | 22 | 72 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.31e-03 | 22 | 72 | 2 | C3711387 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 1.44e-03 | 23 | 72 | 2 | EFO_0004985, GO_1903493 | |
| Disease | Disorder of eye | 1.82e-03 | 212 | 72 | 4 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYRMQRDKEFRLKQS | 46 | Q96LB4 | |
| MYRDFKLRSALIQNK | 136 | Q8N3I7 | |
| IQMLFFSRDRQKYLN | 1521 | Q8NDM7 | |
| NFLLRVNMSKYDAAR | 1946 | Q86UK0 | |
| MDSLLMNRRKFLYQF | 1 | Q9GZX7 | |
| RFDYKDQNFLTLMKR | 186 | P10632 | |
| RFRLDNLLNMAYGVK | 236 | Q14576 | |
| NVRSKNFRLKIYDME | 971 | Q9P1Z9 | |
| DYLRLKKLFAQRMVQ | 3221 | Q9H251 | |
| MKERNIQFQRYNKLR | 2226 | Q8IZT6 | |
| NALRAARLQYLKMAF | 226 | Q9NPF8 | |
| RRKTLFAYKQENEML | 36 | Q8WWK9 | |
| YNDRMFRIKRALDLN | 56 | P14927 | |
| YKAERDRADRLNFML | 786 | P25092 | |
| RRIYANMFKKFAEQD | 406 | Q13451 | |
| SRLDLRYINFKMANL | 231 | Q7L273 | |
| NARLAAEDFRMKYEN | 206 | Q99456 | |
| LNVFLLDMCRKRNDY | 456 | Q9UDY8 | |
| TAFRQYRMNKNFERL | 356 | Q5JU85 | |
| ALANKMGLKFQRYRL | 316 | Q14457 | |
| LFKNEMKRRRDFYAA | 86 | P35226 | |
| KNLLRFDYDRMASLE | 156 | Q5H8C1 | |
| KINNMYRFSLAAFLR | 3511 | Q8NCM8 | |
| FNCLNKRLAKYRMRN | 351 | P51797 | |
| RYKFLNNFDRDMNRL | 576 | Q04446 | |
| RFDYKDQQFLNLMEK | 186 | P33261 | |
| NRLRKYAFELKMNDL | 251 | Q96BY6 | |
| FLRAINQYADMLNKK | 996 | Q14185 | |
| RNEFRRFMEKNPDAY | 581 | Q9H8Y5 | |
| LQKRNMDYFFREQLG | 181 | Q5VU57 | |
| RFRLDNLLNMAYGVK | 236 | Q12926 | |
| AKDLFLQRYQFMRQK | 491 | Q96MM7 | |
| RFDYKDQRFLNLMEK | 186 | P33260 | |
| RFDYKDQQFLNLMEK | 186 | P11712 | |
| RRQLAREKKLYANMF | 401 | Q02790 | |
| RLYEMANLRRQFKEL | 676 | Q14147 | |
| NFDLQKSEALLRKYM | 46 | Q9UDX4 | |
| IFASNLKERMAQRFY | 236 | Q13895 | |
| NRKFLMQELYQRFLD | 601 | B7ZC32 | |
| FIYSLRNRDMKAALR | 286 | Q9P1Q5 | |
| QKRAEMFLSQFNRYN | 306 | A2RUB1 | |
| LKDNFQDQMKRELAY | 886 | P84550 | |
| NYIKSQFLDLNMRKD | 301 | P19087 | |
| KLHYKEFRRFMENLQ | 246 | Q8IYU8 | |
| KKNMARYRDDQDRFI | 1526 | Q7Z443 | |
| EQFDKKYLSQLLMRR | 501 | Q14940 | |
| MDYSRNLEKLAERFL | 61 | P0DMP2 | |
| LKIDEYMRNFSDLRN | 111 | O75688 | |
| RYNDYKLDFRRQQMQ | 171 | Q9BXP5 | |
| FLNAKKLYEDAQMAR | 961 | Q9Y4G8 | |
| LDFRMRLAEVQRQYK | 1481 | O15417 | |
| KFQEAGELYNRMLKR | 1706 | Q14690 | |
| KLYRDVMLENFRNLL | 31 | Q9UK11 | |
| KNLYKDVMLENFRNL | 36 | Q13360 | |
| RFELMRFKTLYNGDN | 511 | Q9Y6Q2 | |
| LYRINAQMKAFRKEL | 871 | Q5TF21 | |
| MDYSRNLEKLAERFL | 61 | O75044 | |
| KLSYRDAKQLNMFLD | 86 | Q9HBJ7 | |
| KNLYRDVMRETFRNL | 26 | Q7L945 | |
| FQDLKKNRMQRFYFD | 471 | Q8TBZ2 | |
| DLRKQRLNEFMAGFY | 1126 | Q9NTJ3 | |
| KMKEFQEANYARVRR | 841 | P78364 | |
| ILEAFVFRMNYSRKN | 686 | Q9ULQ1 | |
| KLYRDVMLENFRNLL | 31 | Q9UJU3 | |
| RDENLKFMKNRDVYS | 2121 | Q9UPU5 | |
| MFFNKDLRRNKAALL | 86 | Q5GH77 | |
| KLYRDVMLENFRNLL | 31 | Q12901 | |
| NQKLKAAYEARMARL | 156 | Q9Y2B5 | |
| KLYRDVMLENFRNLL | 31 | Q9NZL3 | |
| RFAKNYQQLQRDFME | 391 | Q8IWV8 | |
| YMDLKENQRGRFLRI | 156 | Q00577 | |
| RLKDFLRMYANEQER | 191 | Q6PEW1 | |
| KLYRDVMLENFRNLL | 31 | Q9UK12 | |
| KLYRDVMLENFRNLL | 31 | Q2VY69 | |
| CLDFQKMRSALNYRK | 4521 | P20929 |